Skip to main content
. Author manuscript; available in PMC: 2019 Dec 6.
Published in final edited form as: Psychopharmacology (Berl). 2019 Jul 13;236(12):3593–3599. doi: 10.1007/s00213-019-05331-y

Fig. 2.

Fig. 2

α7 nAChR Type I PAM NS1738 did not block nicotine CPP. Mice underwent 3 days of conditioning with either saline (s.c.) or nicotine (0.5 mg/kg). Nicotine produced a robust CPP in mice pre-treated with vehicle. The α7 Type I PAM NS1738 (1 and 10 mg/kg; i.p.) did not alter nicotine reward as measured by the CPP test at both doses tested. Asterisk denotes p < 0.05 from vehicle-vehicle. Each point represents the mean ± SEM of n = 7–10 mice per group